Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial
暂无分享,去创建一个
A. Fyles | M. Bailey | V. Do | J. Vassie | C. Creutzberg | K. Foo | P. Bessette | K. Lim | C. Johnson | C. Haie-Méder | P. Khaw | R. D'amico | J. Cunninghame | L. Mileshkin | J. Dixon | M. Powell | O. Cook | K. Kahl | C. Gordon | A. Moore
[1] M. Mix,et al. The impact of radiotherapy protocol adherence on the outcome of patients with locally advanced NSCLC treated with concurrent chemoradiation: results from the radiotherapy quality assurance of the multicentre international randomized PET-Plan trial. , 2021, Radiotherapy and Oncology.
[2] Samsara Terparia,et al. Automatic evaluation of contours in radiotherapy planning utilising conformity indices and machine learning , 2020, Physics and imaging in radiation oncology.
[3] C. Kirisits,et al. Implementing an online radiotherapy quality assurance programme with supporting continuous medical education - report from the EMBRACE-II evaluation of cervix cancer IMRT contouring. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] V. Grégoire,et al. Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma , 2020, Frontiers in Oncology.
[5] H. Putter,et al. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial , 2019, The Lancet. Oncology.
[6] D. Dearnaley,et al. Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).
[7] T. Kasamatsu,et al. Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402) , 2019, Radiation oncology.
[8] Annette Haworth,et al. Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans‐Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise , 2019, Journal of medical imaging and radiation oncology.
[9] Michael G Jameson,et al. PO-0823: TRAC: Automated atlas based machine learning QA of contouring accuracy for the PROMETHEUS trial , 2018 .
[10] H. Putter,et al. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] J. Staffurth,et al. Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy , 2017, Radiation oncology.
[12] P. Metcalfe,et al. Results of the Australasian (Trans‐Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC‐3 trial , 2016, Journal of medical imaging and radiation oncology.
[13] A. Kneebone,et al. Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy. , 2015, International journal of radiation oncology, biology, physics.
[14] M. Tomsej,et al. Quality assurance for the EORTC 22071–26071 study: dummy run prospective analysis , 2014, Radiation oncology.
[15] M. Shinoda,et al. Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303 , 2012, International Journal of Clinical Oncology.
[16] Brian O'Sullivan,et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] W. Small,et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. , 2008, International journal of radiation oncology, biology, physics.
[18] N. Spry,et al. Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] A. Rockall,et al. An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[20] P. Lambin,et al. Quality Assurance in the EORTC Randomized Trial 22922/10925 Investigating the Role of Irradiation of the Internal Mammary and Medial Supraclavicular Lymph Node Chain Works , 2006, Strahlentherapie und Onkologie.
[21] R. Reznek,et al. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. , 2005, International journal of radiation oncology, biology, physics.